These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3730789)

  • 1. Effect of the cyclo-oxygenase inhibitor indobufen on platelet accumulation in prosthetic vascular grafts.
    Lane IF; Irwin JT; Jennings SA; Poskitt KR; Meek AC; McCollum CN
    Br J Surg; 1986 Jul; 73(7):563-5. PubMed ID: 3730789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting.
    Rajah SM; Nair U; Rees M; Saunders N; Walker D; Williams G; Critchley A; Beton D; Campbell C; Lawson RA
    J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1146-53. PubMed ID: 8159037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indobufen compared with aspirin and dipyridamole on graft patency after coronary artery bypass surgery: results of a combined analysis.
    Cataldo G; Heiman F; Lavezzari M; Marubini E
    Coron Artery Dis; 1998; 9(4):217-22. PubMed ID: 9649928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of indobufen on the thrombogenic potential of a Dacron prosthesis in an artificial circulation.
    Sheehan SJ; Monson JR; Salter MC; Rajah DS; Rajah SM; Kester RC
    Eur J Vasc Surg; 1988 Aug; 2(4):223-7. PubMed ID: 2975227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of indobufen on aortocoronary bypass patency after 1 week and after 1 year].
    Rohn V; Pirk J; Mach T
    Cor Vasa; 1993; 35(4):162-4. PubMed ID: 8403942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indobufen: an updated review of its use in the management of atherothrombosis.
    Bhana N; McClellan KJ
    Drugs Aging; 2001; 18(5):369-88. PubMed ID: 11392445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ticlopidine versus aspirin and dipyridamole: influence on platelet deposition and three-month patency of polytetrafluoroethylene grafts.
    Hansen KJ; Howe HR; Edgerton TA; Faust KB; Kon ND; Geisinger KR; Meredith JH
    J Vasc Surg; 1986 Aug; 4(2):174-8. PubMed ID: 3735571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic treatment of vascular diseases with indobufen].
    Belcaro G; Errichi BM; Laurora G; Marinucci R; Cesarone MR; De Cenzo A
    Minerva Cardioangiol; 1989 May; 37(5):241-50. PubMed ID: 2779803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indobufen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cerebral, peripheral and coronary vascular disease.
    Wiseman LR; Fitton A; Buckley MM
    Drugs; 1992 Sep; 44(3):445-64. PubMed ID: 1382938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of platelet inhibitory therapy on graft thromboresistance.
    Bearn PE; Bull H; Seddon AM; Marston A; McCollum CN
    Int J Exp Pathol; 1993 Oct; 74(5):425-31. PubMed ID: 8217777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet inhibitory drugs: an in vivo method of evaluation in patients.
    Norcott HC; Goldman M; Hawker RJ; Rafiqi EI; Drolc Z; McCollum CN
    Thromb Haemost; 1982 Dec; 48(3):307-10. PubMed ID: 6761890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of platelet inhibitory therapy on prosthetic graft maturation.
    Bearn PE; Moffat C; Seddon AM; Bull H; Marston A; Fox B; McCollum CN
    Int J Exp Pathol; 1993 Feb; 74(1):1-8. PubMed ID: 8471529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of thromboxane receptor blockade versus thromboxane synthase inhibition on canine arterial graft patency.
    Bech FR; Cronenwett JL; McDaniel MD; Ogletree ML; Freeman DH
    J Vasc Surg; 1990 Aug; 12(2):119-25. PubMed ID: 2143235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet antagonists eliminate thromboembolic complications of small-diameter arterial prostheses.
    Nordestgaard AG; Buckels JA; Wilson SE
    J Vasc Surg; 1987 Jan; 5(1):110-7. PubMed ID: 3795377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of indium-111 platelet deposition on Dacron vascular grafts in humans by aspirin plus dipyridamole.
    Stratton JR; Ritchie JL
    Circulation; 1986 Feb; 73(2):325-30. PubMed ID: 2935327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet therapy reduces aortic intimal hyperplasia distal to small diameter vascular prostheses (PTFE) in nonhuman primates.
    Hagen PO; Wang ZG; Mikat EM; Hackel DB
    Ann Surg; 1982 Mar; 195(3):328-39. PubMed ID: 7059243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and dipyridamole reduce platelet deposition on prosthetic femoro-popliteal grafts in man.
    Goldman MD; Simpson D; Hawker RJ; Norcott HC; McCollum CN
    Ann Surg; 1983 Dec; 198(6):713-6. PubMed ID: 6227296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indobufen vs acetylsalicylic acid plus dipyridamole in long-term patency after femoropopliteal bypass.
    D'Addato M; Curti T; Bertini D; Donini I; Ferrero R; Fiorani P; Pellegrino F; Vecchioni R; Visconti W; Zinicola N
    Int Angiol; 1992; 11(2):106-12. PubMed ID: 1402213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre- vs postoperative pharmacologic inhibition of platelets: effect on intimal hyperplasia in canine autogenous vein grafts.
    Dobrin PB; Golan J; Fareed J; Blakeman B; Littoy FN
    J Cardiovasc Surg (Torino); 1992; 33(6):705-9. PubMed ID: 1287008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different patterns of inhibition of adrenaline-induced platelet aggregation and kinetics in vivo by acetylsalicylic acid and indobufen.
    Fortunato JS; Pinheiro MJ; Monteiro MC; Rodrigues MA; Amaral I
    J Int Med Res; 1991; 19(4):305-17. PubMed ID: 1916004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.